Polymers as biomaterials for tissue engineering and controlled drug delivery

被引:339
作者
Nair, Lakshmi S.
Laurencin, Cato T. [1 ]
机构
[1] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA
[2] Univ Virginia, Coll Med, Dept Orthopaed Surg, Charlottesville, VA 22903 USA
[3] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA
来源
TISSUE ENGINEERING I: SCAFFOLD SYSTEMS FOR TISSUE ENGINEERING | 2006年 / 102卷
关键词
biodegradable polymers; drug delivery; polymeric biomaterials; tissue engineering;
D O I
10.1007/b137240
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The advent of biodegradable polymers has significantly influenced the development and rapid growth of various technologies in modern medicine. Biodegradable polymers are mainly used where the transient existence of materials is required and they find applications as sutures, scaffolds for tissue regeneration, tissue adhesives, hemostats, and transient barriers for tissue adhesion, as well as drug delivery systems. Each of these applications demands materials with unique physical, chemical, biological, and biomechanical properties to provide efficient therapy. Consequently, a wide range of degradable polymers, both natural and synthetic, have been investigated for these applications. Furthermore, recent advances in molecular and cellular biology, coupled with the development of novel biotechnological drugs, necessitate the modification of existing polymers or synthesis of novel polymers for specific applications. This review highlights various biodegradable polymeric materials currently investigated for use in two key medical applications: drug delivery and tissue engineering.
引用
收藏
页码:47 / 90
页数:44
相关论文
共 202 条
[11]   In vitro bone biocompatibility of poly(anhydride-co-imides) containing pyromellitylimidoalanine [J].
Attawia, MA ;
Uhrich, KE ;
Botchwey, E ;
Langer, R ;
Laurencin, CT .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1996, 14 (03) :445-454
[12]   CYTOTOXICITY TESTING OF POLY(ANHYDRIDE-CO-IMIDES) FOR ORTHOPEDIC APPLICATIONS [J].
ATTAWIA, MA ;
UHRICH, KE ;
BOTCHWEY, E ;
FAN, M ;
LANGER, R ;
LAURENCIN, CT .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1995, 29 (10) :1233-1240
[13]  
Attawia MA, 1999, J BIOMED MATER RES, V48, P322, DOI 10.1002/(SICI)1097-4636(1999)48:3<322::AID-JBM17>3.0.CO
[14]  
2-U
[15]   Regional drug delivery with radiation for the treatment of Ewing's sarcoma - In vitro development of a taxol release system [J].
Attawia, MA ;
Borden, MD ;
Herbert, KM ;
Katti, DS ;
Asrari, F ;
Uhrich, KE ;
Laurencin, CT .
JOURNAL OF CONTROLLED RELEASE, 2001, 71 (02) :193-202
[16]  
BAE YH, 1998, FRONTIERS TISSUE ENG, P261
[17]  
BAEYER HV, 1988, J MEMBRANE SCI, V36, P215
[18]  
Barbucci R., 2002, INTEGRATED BIOMATERI
[19]  
Barrows T.-H., 1994, BIOMEDICAL POLYM DES
[20]   CONTROLLED GROWTH-FACTOR DELIVERY INDUCES DIFFERENTIAL NEURITE OUTGROWTH IN 3-DIMENSIONAL CELL-CULTURES [J].
BEATY, CE ;
SALTZMAN, WM .
JOURNAL OF CONTROLLED RELEASE, 1993, 24 (1-3) :15-23